54Indexed trials
Market Rank #39 · Evidence Tier A
Puerto Rico
Neuroscience Intelligence
Puerto Rico neuroscience intelligence: 54 indexed trials, 3 institutions, research score 25.72.
12Recruiting
3Research institutions
25.7Research score
Evidence profile
29Sponsors
17Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 26 · ML priority 26 · Confidence 100 · Evidence 25.7
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
alzheimers12trials
epilepsy5trials
pain_neuropathy5trials
multiple_sclerosis3trials
parkinsons3trials
stroke2trials
als2trials
depression2trials
other_neurology2trials
schizophrenia2trials
Leading indexed sponsors
Eli Lilly and Company8trials
Novartis Pharmaceuticals4trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
Pfizer3trials
AbbVie3trials
Novo Nordisk A/S3trials
GlaxoSmithKline3trials
Axsome Therapeutics, Inc.2trials
Hoffmann-La Roche2trials
Kodiak Sciences Inc2trials